跳至主要内容
临床试验/ISRCTN52588893
ISRCTN52588893进行中(未招募)未知

Sarscov2 immunity Evaluation post-vaccination iN patIentS On Renal replacement therapy

Royal Liverpool University Hospital0 个研究点目标入组 750 人开始时间: 2021年11月15日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Age of 18 years or older
  • 2. Renal Replacement Therapy patients (dialysis and renal transplant) who have received the SARS-CoV-2 vaccine
  • 3. A comparative arm of Renal Replacement Therapy patients (dialysis and renal transplant) who have refused the SARS-CoV-2 vaccine
  • 4. Capable of understanding the purpose and risks of the study, fully informed and given informed consent

排除标准

  • 1. Pregnancy or breastfeeding
  • 2. Active (haematological) malignancy
  • 3. Inherited immune deficiency
  • 4. Infection with Human Immunodeficiency Virus (HIV)

研究者

相似试验